References
- Nance, ST, ed. Immune destruction of red blood cells. Arlington, VA: American Association of Blood Banks, 1989.
- Issitt PD, Anstee DJ. Applied blood group serology. 4th ed. Durham, NC: Montgomery Scientific Publications, 1998.
- Auffray I, Marfatia S, De Jong K, et al. Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice. Blood 2001;97:2872-8.
- Jordan MB, Van Rooijen N, Izui S, Kappler J, Marrack P. Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model. Blood 2003;101:594-601.
- Duncan AR, Winter G. The binding site for C1q on IgG. Nature 1988;332:738-40.
- von dem Borne AE, Beckers D, Engelfriet CP. Mechanisms of red cell destruction mediated by non-complement binding IgG antibodies: the essential role in vivo of the Fc part of IgG. Br J Haematol 1977;36:485-93.
- Steenken C, Borner P, Mariss P, et al. [Elimination of rhesus (D)-incompatible erythrocytes by (Fab')2 G-anti-D (author’s transl)]. Z Immunitatsforsch Exp Klin Immunol 1975;150:283-99.
- Yazdanbakhsh K, Kang S, Tamasauskas D, Sung D, Scaradavou A. Complement receptor 1 inhibitors for prevention of immune-mediated red cell destruction: potential use in transfusion therapy. Blood 2003;101:5046-52.
- Gold HK, Gimple LW, Yasuda T, et al. Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris. J Clin Invest 1990;86:651-9.